Author:
Castellino Sharon M.,Allen Kristen E.,Pleasant Katherine,Keyes Graham,Poehling Katherine A.,Tooze Janet A.
Funder
Wake Forest Vaccine Center
Comprehensive Cancer Center at Wake Forest Baptist Medical Center
National Cancer Institute
Wake Forest Biostatistics and Bioinformatics Shared Resource
Publisher
Springer Science and Business Media LLC
Subject
Oncology(nursing),Oncology
Reference52 articles.
1. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65:1405–8.
2. Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64:300–4.
3. Garland SM, Brotherton JML, Moscicki AB, Kaufmann AM, Stanley M, Bhatla N, et al. HPV vaccination of immunocompromised hosts. Papillomavirus Res. 2017 [cited 2018 May 10];4:35–8. Available from:
http://linkinghub.elsevier.com/retrieve/pii/S2405852117300253
.
4. Stobbe M. Vaccine panel gives nod to HPV shots for men up to age 26. Associated Press; 2019. Available from:
https://www.apnews.com/e341072cbfa040369fd157bd255ed40a
.
5. Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66:874–82.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献